The EMERALD study
Trial status: active not recruiting Trial ID: NCT06823713 What is the EMERALD study? EMERALD is a clinical trial designed to test if a new treatment called RTX001 is safe, easy to cope with, and works well for people suffering from decompensated liver cirrhosis. The...
New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease
A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to the Commission, working alongside...
The MATCH trial – testing Macrophage cells to treat liver cirrhosis
This page is a summary of the MATCH trial. The trial looked at the possibility of using a type of white blood cell called a macrophage to treat liver cirrhosis. What are macrophages? We have lots of different types of white blood cell. They all have different jobs in...
The OPAL study
Trial status: Active, not recruiting Trial ID: NCT06380335 What is OPAL? OPAL is an observational study sponsored by Resolution Therapeutics. 11 hospitals across England and Scotland are participating in the study. OPAL stands for Observational Study in PArticipants...